Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Belgium Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20081
20091
20102
20112
20121
20134
20141
20151
20162
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status2
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Novartis Pharmaceuticals4
Kiadis Pharma2
Zwi Berneman2
Boehringer Ingelheim1
Carlos Graux, MD, PhD1
Celgene1
Cogent Biosciences, Inc.1
GlaxoSmithKline1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute21
Leukemia8
Myelodysplastic Syndromes7
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Hematologic Neoplasms4
Myeloproliferative Disorders4
Leukemia, Myelomonocytic, Chronic3
Multiple Myeloma3
Neoplasms3
Graft vs Host Disease2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.